KI & Tech

DiffusionGemma: 4x faster text generation

Investing in multi-agent AI safety research

Google DeepMind and partners announce a $10M funding call for multi-agent safety research.

Fluid, natural voice translation with Gemini 3.5 Live Translate

Gemini 3.5 Live Translate brings near real-time, natural speech translation to Google AI Studio, Google Translate and Google Meet.

Introducing Gemma 4 12B: a unified, encoder-free multimodal model

Powering the future of robotics in Europe

Measuring the impact of learning with AI in Sierra Leone and beyond

Results from a randomized controlled trial show the potential of Gemini’s Guided Learning feature to boost engagement and accelerate learning.

We’re launching the Google DeepMind Accelerator program in Asia Pacific to tackle environmental risks

Fast-tracking genetic leads to reverse cellular aging

Biologists use Co-Scientist to find novel factors that successfully rejuvenate human cells.

Simulate real-world places with Project Genie and Street View

We’re expanding access to Google AI Ultra subscribers globally and introducing a new capability powered by Street View.

Introducing Gemini Omni

Introducing Google Antigravity 2.0

Gemini for Science: AI experiments and tools for a new era of discovery

A collection of science tools and experiments to expand the scale and precision of scientific exploration.

Making it easier to understand how content was created and edited

We're expanding our tools to help you understand how content was created and edited across the web.

Strengthening Singapore’s AI Future: A New National Partnership

Google DeepMind and Singapore partner to apply frontier AI to address complex challenges across health, education, and sustainability and more.

Finding the molecular switches behind new infectious diseases

Clare Bryant uses Co-Scientist to identify genetic triggers in emerging infectious diseases.

Opening new paths in aging research

Calico Life Sciences uses Co-Scientist to connect scattered findings and generate new leads in aging research.

Accelerating discovery of liver disease mechanisms

Filippo Menolascina uses Co-Scientist to identify new liver disease treatments and explain why existing drugs only help certain patients.

Uniting biological toolkits for a new approach to ALS

Co-Scientist unites Boston Children’s Hospital and MIT’s labs to explore new RNA-based treatments for ALS.